Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Breast Cancer

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 50%High 1 · 50%

Platinum‐containing chemotherapy vs chemotherapy without platinum

Participants requiring chemotherapy delays · early triple‐negative breast cancer

Platinum‐containing chemotherapy leads to higher participants requiring chemotherapy delays compared with chemotherapy without platinum (high certainty).

1 finding from 1 review

Platinum‐based chemotherapy for early triple‐negative breast cancer 2023 · Cochrane Headline outcomes only
RR 2.23 [1.7, 2.94]
5 studies · 1053 participants
High

Platinum‐containing chemotherapy vs chemotherapy without platinum

Participants requiring dose reduction · early triple‐negative breast cancer

Platinum‐containing chemotherapy probably leads to higher participants requiring dose reduction compared with chemotherapy without platinum (moderate certainty).

1 finding from 1 review

Platinum‐based chemotherapy for early triple‐negative breast cancer 2023 · Cochrane Headline outcomes only
RR 1.77 [1.56, 2.02]
8 studies · 2055 participants
Moderate